Long QT syndrome (LQT) is an inherited disorder that causes sudden death from cardiac arrhythmias, specifically torsade de pointes and ventricular fibrillation.
Introduction
Although sudden death from cardiac arrhythmias is thought to account for 11% of all natural deaths, the mechanisms underlying arrhythmias are poorly understood (Kannel et al., 1987; Willich et al., 1987) . Long QT syndrome (LQT) is an inherited cardiac arrhythmia that causes abrupt loss of consciousness, seizures, and sudden death from ventricular tachyarrhythmias, specifically torsade de pointes and ventricular fibrillation (Ward, 1964; Romano, 1965; Schwartz et al., 1975; Moss et al., 1991) . Autosomal dominant and autosomal recessive forms of this disorder have been reported. Autosomal recessive LQT (also known as JervelI-Lange-Nielson syndrome) has been associated with congenital neural deafness; this form of LQT is rare (Jervell and Lange-Nielson, 1957) . Autosomal dominant LQT (Romano-Ward syndrome) is more common and is not associated with other phenotypic abnormalities. A disorder very similar to inherited LQT can also be acquired, usually as a result of pharmacologic therapy (Schwartz et al., 1975; Zipes, 1987) .
We have used two strategies to identify LQT genes, a candidate gene approach and positional cloning. Positional information is now available for three LQT loci, as we have mapped LQT1 to chromosome 1 lp15.5 (Keating et al., 1991 (Keating et al., a, 1991 , LQT2 to 7q35-36, and LQT3 to 3p21-24 (Jiang et al., 1994) . The candidate gene approach relies on likely mechanistic hypotheses based on physiology. Although little is known about the physiology of LQT, the disorder is associated with prolongation of the QT interval on electrocardiograms, a sign of abnormal cardiac repolarization. This association suggests that genes encoding ion channels (or their modulators) are reasonable candidates for LQT. This hypothesis is now supported by our recent discovery that chromosome 7-1inked LQT results from mutations in the human ether-a-go-go-related gene (HERG), a putative cardiac potassium channel gene (Curran et al., 1995 [this issue of Ce//]). A neuroendocrine calcium channel gene (CACNLIA2; Chin et al., 1991; Seino et al., 1992) and agene encoding a GTP-binding protein that modulates potassium channels (GNAI2; Weinstein et al., 1988; Magovcevic et al., 1992) became candidates for LQT3 based on their chromosomal location. Subsequent linkage analyses, however, have excluded these genes (Q. W. and M. T. K., unpublished data).
In theory, mutations in a cardiac sodium channel gene could cause LQT. Voltage-gated sodium channels mediate rapid depolarization in ventricular myocytes and also conduct a small current during the plateau phase of the action potential (Attwell et al., 1979) . Subtle abnormalities of sodium channel function (e.g., delayed sodium channel inactivation or altered voltage dependence of channel inactivation) could delay cardiac repoiarization, leading to QT prolongation and arrhythmias. A few years ago, Gellens et al. (1992) cloned and characterized a cardiac sodium channel gene, SCN5A. The structure of this gene was similar to previously characterized sodium channels, encoding a large protein of 2016 amino acids. These channel proteins contain four homologous domains (DI-DIV), each of which contains six putative membrane-spanning segments ($1-$6). SCN5A was recently mapped to chromosome 3p21, making it an excellent candidate gene for LQT3 (George et al., 1995) .
In this study, we provide evidence suggesting that SCN5A is LQT3. We used genotypic analyses to show that SCN5A was tightly linked to LQT3 in three unrelated families. We then identified the same Jntragenic deletion of SCN5A in affected members of two of these families.
These deletions disrupted sequences within a region of known importance for sodium channel inactivation, suggesting a likely cellular mechanism for chromosome 3-1inked LQT. /S6; IDIII-IV  21  2R  ACCCAGCCCAGTGGGGAGCTGGT   3L  CCATGCTGGGGCCTCTGAGAAC  IDIII-IV  22  4R  GGCTCTGATGGCTGGCCATGTG   5L  CCCAGCGAGCACTTTCCATTTG  IDIII-IV; DIV/S1-S3  23  6R  GCTTCTCCGTCCAGCTGACTTGTA   7L . GAGCCCAGCCGTGGGCATCCT DIV/S6 24 8R GTCCCCACTCACCATGGGCAG All primers are shown in 5' to 3' direction. Sense strand oligonucleotides are indicated with an L and antisense oligonucleotides are indicated with an R. D, domain; ID, interdomain; S, membrane-spanning segment.
Results

Genetic Linkage of SCNSA and LQT3
In 1995, SCN5A was mapped to chromosome 3p21 (George et al., 1995) . To test the candidacy of SCNSA for LQT, we used single strand conformation polymorphism (SSCP) analyses to identify polymorphisms within this gene and then performed linkage analyses in chromosome 3-1inked families. Since the genomic structure of SCN5A was unknown, we designed oligonucleotide primer pairs from published SCNSA cDNA sequences (Gellens et al., 1992) , based on the assumption that the genomic structure of SCN5A would be similar to the known structure of SCN4A, the skeletal muscle sodium channel gene (McClatchey et al., 1992a) . Primer pairs that gave appropriately sized products from genomic DNA were used to screen DNA samples from patients. An aberrant SSCP conformer was identified using primer pair 7-8 ( Table 1) . The normal and aberrant bands were cloned and sequenced. The aberrant conformer resulted from a C to T substitution at position 3 of codon 1819 (cDNA nucleotide 5607; Gellens et al., 1992) . This substitution did not affect the predicted amino acid sequence of the product of SCN5A. The observed heterozygosity for this polymorphism was <0.50. The SCN5A polymorphism was used for genotypic analyses in chromosome 3-1inked families ( Figure 1 ). No recombination events between SCN5A and LQT were identified in any of these families. The maximum combined two-point Iod score for all chromosome 3-1inked families was 2.74 at a recombination fraction of 0.0 ( Lod scores were calculated assuming autosomal dominant inheritance with a penetrance of 0.90 for all kindreds, as indicated by segregation analysis of these and other LQT kindreds. We assumed a disease allele frequency of 0.001 and that female and male recombination frequencies were equal. When penetrance was varied from 70%-100%, the maximum combined two-point Iod score for linkage between SCN5A 3-4 and LQT3 ranged from 4,85 to 5.91, respectively. The results for SCN5A 7-8 varied from 2.26 (700/0) to 3.01 (100%). Z,,~ = 5.54, 0 = 0.00; Z~ indicates maximum Iod score, e indicates estimated recombination fraction at Zm,=. b Z,,~., = 2.74, 0 = 0.00. cDNA sequences. To facilitate this work, we isolated and partially characterized two genomic P1 clones. These clones spanned the entire gene and were used to begin determining the genomic structure of SCN5A. We hypothesized that LQT-causing mutations would be subtle (e.g., missense mutations or small in-frame deletions) and might affect delayed inactivation of encoded sodium channels or alter the voltage dependence of channel inactivation. We focused, therefore, on regions of known importance for channel inactivation. Primers based on sequences predicted to encode the cytoplasmic region between Dill and DIV were synthesized. This region corresponds to exons 21-23 of SCN4A and is known to be critical for channel inactivation. These primers were used to characterize the flanking introns by cycle sequencing. Additional primers were designed to these intronic sequences (see Table 1 ).
When primer pair 3 -4 was used in SSCP analyses, an The pedigree structure for kindred 2321 is shown. The results of polymerase chain reaction (PCR) analyses using primer pair 3-4 and denaturing polyacrylamide gel electrophoresis are shown below each symbol. Note that the 235 bp allele cosegregates with the disease in this family, indicating the presence of a disease-associated intragenic deletion of SCN5A. To avoid phenotypic misclassification, the phenotypic criteria used in this study were stringent, and many individuals were classified as having an uncertain phenotype. Individuals with a QTc of 0.47 s or greater were classified as affected, whereas individuals with a QTc of 0.41 s or less were considered unaffected. All other individuals were classified as uncertain. If typical criteria were used (individuals With a QTc of 0.44 s or greater considered affected and individuals with a QTc less than 0.44 s classified as normal), all affected members of kindreds 2321 and 2322 would carry the SCN5A deletion and all unaffected individuals would carry only the normal allele.
anomalous conformer was identified in DNA samples from affected members of kindreds 2321 and 2322 ( Figure 1 ). By contrast, only the normal conformer was seen in DNA samples from unaffected members of these families. The combined two-point Iod score for linkage between this anomaly and LQT3 was 5.54 (Table 2) . Again, no recombination was observed between SCN5A and LQT3, indicating that these loci are tightly linked.
Identical SCN5A Intragenic Deletions Associated with LQT in Two Unrelated Families
The mobility shift between the aberrant and normal SSCP conformers identified in kindreds 2321 and 2322 was large, suggesting the possibility of a small deletion. To test this hypothesis, the conformers were separated by electrophoresis on denaturing polyacrylamide gels (Figures 2 and 3 ). These data demonstrated the presence of two products of 235 bp and 244 bp. The 235 bp product was only seen in affected individuals. Furthermore, this aberrant conformer was not observed in more than 500 control individuals (data not shown). These data indicate that an intragenic deletion of SCNSA is the likely cause of LQT in these families. To determine the effect of the LQT-associated deletion on SCNSA structure, we amplified the normal and aberrant SSCP conformers and performed cycle sequencing. These experiments revealed the presence of a 9 bp deletion beginning at nucleotide 4661 of the cDNA ( Figure 4A ). We also cloned and sequenced the aberrant and normal SSCP conformers. These experiments confirmed the size and location of the deletion. This deletion disrupts the coding sequence, resulting in a deletion of three conserved amino acids, Lys-1505-Pro-1506-GIn-1507 (KPQ), in the cytoplasmic linker between Dill and DIV ( Figures 4B and 5) .
DNA sequence analyses of the aberrant conformer in kindred 2321 indicated that the intragenic deletion was identical to that found in kindred 2322 (data not shown). One possible explanation for the identical deletions in these two kindreds is that they are distantly related. Both families were North American of European descent, one German and the other English. Examination of a genealogy data base failed to reveal a relationship between these families for more than eight generations. Furthermore, genotypic analyses of these kindreds indicated different hapIotypes on the disease chromosome (see Figure 1) . The presence of identical deletions in two apparently unrelated LQT families strongly suggests that SCNSA is LQT3.
Discussion
We conclude that mutations in the cardiac sodium channel gene SCN5A are the likely cause of chromosome 3-1inked LQT. Several lines of evidence support this conclusion. First, we identified genetic linkage between SCN5A and LQT3 in three unrelated families. No recombination was identified between these loci. Second, we identified identical intragenic deletions of SCNSA in affected members of two LQT families. This deletion was not identified in more than 500 control individuals. Third, SCNSA is the cardiac sodium channel gene. Subtle mutations of this gene would be expected to cause an LQT phenotype. Finally, the type (an in-frame deletion of three amino acids) and location (a region of known importance for sodium channel inactivation) of the deletions support the conclusion that SCN5A is LQT3. Additional evidence supports a role for SCN5A in the pathogenesis of LQT. Pharmacologic data, for example, suggest that abnormal cardiac sodium channel function could cause LQT. Toxins and drugs that slow the rate of sodium channel inactivation or that shift the voltage dependence of channel activation or inactivation can prolong cardiac action potential duration and induce arrhythmias (Honerjager, 1982) . Molecular genetic studies also support a link between sodium channel inactivation and clinical electrophysiologic abnormalities. Studies of hyperkalemic periodic paralysis and paramyotonia congenita indicate that missense mutations in the skeletal muscle sodium channel gene (SCN4A) cause myotonia (Fontaine et al., 1990; Ptacek et al., 1991 Ptacek et al., , 1992 Rojas et al., 1991; McClatchey et al., 1992b McClatchey et al., , 1992c Ebers et al., 1991; Rudolph et al., 1992; Lerche et al., 1993) . Physiologic data show that these mutations affect sodium channel inactivation, leading to repetitive depolarizations, consistent with the myotonic phenotype (Yang et al., 1994) . By analogy, similar mutations in the cardiac sodium channel gene could cause a phenotype like LQT.
We have also demonstrated that mutations in HERG, a putative cardiac potassium channel gene, cause the chromosome 7-1inked form of LQT (Curran et al., 1995) . The mutations that we identified in HERG, along with the biophysics of potassium channel ~ subunits, suggest that chromosome 7-1inked LQT results from dominant negative mutations and a resultant reduction in functional channels. In chromosome 3-1inked LQT, by contrast, the LQTassociated deletions identified in SCN5A are likely to result in functional cardiac sodium channels with altered properties, such as delayed inactivation or altered voltage dependence of channel inactivation. Delayed sodium channel inactivation would increase inward sodium current, depolarizing the membrane. This effect is similar to the altered membrane potential expected from HERG mutations, in which outward potassium current is decreased. It is unlikely that more deleterious mutations of SCN5A would cause LQT. A reduction of the total number of cardiac sodium channels, for example, would be expected to reduce action potential duration, a phenotype opposite that of LQT. The mutations described in this study cause the deletion of three amino acids, KPQ, in the cytoplasmic linker between Dill and DIV. The KPQ sequence is highly conserved, suggesting the presence of genetic pressure for its conservation during evolution ( Figure 4B ). The cytoplasmic peptide segment that links Dill and DIV is the region responsible for fast inactivation (West et al., 1992) . Heterologous expression of neural sodium channels in the form of two polypeptides lacking this DIII-DIV linker results in a sodium current with greatly slowed inactivation (Stuhmer et al., 1989) . Site-directed mutagenesis studies of this region in SCN4A have focused on another amino acid triplet, Ile-1488-Phe-1489-Met-1490 (IFM). Mutations of these amino acids to glutamine residues eliminate sodium channel fast inactivation, but leave slow inactivation intact (West et al., 1992) . It will be of interest to determine whether the KPQ deletion has a similar functional effect on cardiac sodium channel inactivation. Our data predict a likely cellular mechanism for chromosome 3-1inked LQT. Delayed myocellular sodium channel inactivation would prolong action potential duration and the QT interval. Excessive prolongation could result in reactivation of L-type calcium or sodium channels, thereby leading to secondary depolarizations, a likely mechanism of torsades de pointes (Antzelevitch and Sicouri, 1994) .
We have not yet identified a mutation in SCN5A in kindred 2171, the third chromosome 3-1inked LQT family. Although the disease phenotype in this kindred appears to be linked to SCN5A, SSCP analyses of sequences encoding the putative inactivation region failed to show a deletion or other anomalies. Presumably, the disease in this family results from SCN5A mutations in another region of this approximately 35 kb gene. Mutational analyses of hyperkalemic periodic paralysis and paramyotonia congenita families have demonstrated several other regions of SCN4A that are important for channel inactivation (Fontaine et al., 1990; Ptacek et al., 1991 Ptacek et al., , 1992 Rojas et al., 1991; McClatchey et al., 1992b, 19~2c; Ebers et al., 1991 ; Rudolph et al., 1992; Lerche et al., 1993) . Once we have determined the genomic structure of SCN5A, we will screen for additional LQT-causing mutations.
Although LQT kindreds 2321 and 2322 appear unrelated, both had the same KPQ deletion. The haplotype of the affected chromosome in each family was distinct, but this does not exclude the possibility of a distant relationship. Continued genotypic analysis of sequences near SCN5A may help determine whether these deletions are distinct.
Presymptomatic diagnosis of LQT has depended on identification of QT prolongation on electrocardiograms. Unfortunately, electrocardiograms are rarely performed in young, healthy individuals. In addition, many LQT gene carriers have relatively normal QT intervals, and the first sign of disease can be a fatal cardiac arrhythmia (Vincent et al., 1992) . Now that two LQT genes have been identified, we can begin to contemplate genetic testing for this disorder. This will require continued mutational analyses and identification of additional LQT genes. With more detailed phenotypic analyses, we may also discover phenotypic differences among the varied forms of LQT. These differences may be useful for diagnosis and treatment.
In summary, we have identified a gene, SCN5A, that is likely to cause LQT. Along with our finding that mutations in HERG cause the chromosome 7-1inked form of LQT, this discovery further supports the hypothesis that LQT results from mutations in cardiac ion channels.
Experimental Procedures
LQT Kindreds
This investigation was performed on three previously described LQT kindreds (Jiang et al., 1994) . Phenotypic criteria were identical to those used in our previous studies (Keating et al., 1991a (Keating et al., , 1991b Keating, 1992) . Individuals were evaluated for LQT based on the QT interval corrected for heart rate (QTc; Bazette, 1920) and on the presence of syncope, seizures, and aborted sudden death. Informed consent was obtained from individuals or their guardians, in accordance with local institutional review board guidelines. Phenotypic data were interpreted without knowledge of genotype.
Linkage Analyses
Pairwise linkage analysis was performed using MLINK in LINKAGE version 5.1 (Lathrop et al., 1985) . As in our previous studies, we assumed a penetrance of 0.90 and an LQT gene frequency of 0.001 (Keating et al., 1991a (Keating et al., , 1991b . Gene frequency was assumed to be equal between males and females.
Isolation of SCNSA Genomic Clones and Partial Characterization of Genomic Structure
SCN5A probes we re generated using the products of PCRs with human genomic DNA and primer pairs based on SCN5A cDNA sequences. One primer pair, 5'-ACTTTCATCGTACTGAATAAAGGCAA-3' and 5'-GAGTGAACCAGAATCI-rCACA G C-3', was designed from 5'coding sequences and yielded the predicted product of 118 bp. The second primer pair, 5'-GGACCGTGAGTCCATCGTGTGA-3' and 5'-AGCCCA-TTCACAACATATACAGTCT-3', was derived from the 3' noncoding sequences and yielded a product of 336 bp. The third primer pair, 5'-AGCAACI-ICATCCCAGCTGCTGAG-3' and 5'-CTCCCAGCATC-TCAGGTCAAGTG-3', was based on 3' noncoding sequences and yielded a product of 297 bp. These PCR products were purified from 2% agarose gels, radiolabeled to high specific activity, and used to screen a human genomic P1 library (Sternberg, 1990) .
To characterize the genomic structure of SCN5A exons encoding the cytoplasmic linker between DIII-DIV, we designed sequencing primers based on cDNA sequences and predicted genomic structure (McClatchey et al., 1992a; Gellens et al., 1992) . The primer pair for presumed exon 21 (based on the structure of SCN4A) was 5'-TATG-AAGAGCAGCCTCAGTGGGAA-3' and 5'-CI I I I I CFFCTGTFGGTT-GAAGTTG-3'. Primers for presumed exon 22 were 5'-TTAGGGG-GCCAGGACATCTTC-3' and 5'-CAGGGGCCGTGGGATGGGCTTC-TGG-3'. Primers for presumed exon 23 were 5'-CACCATATTCAAGCA-GATCAG-3' and 5'-CTGCGCCACTACTACTTCACC-3'. These primers were used to determine intronic sequences from SCN5A clones as described previously (Wang and Keating, 1994) .
SSCP Analyses
Genomic DNA samples were amplified by PCR and used in SSCP analyses as described previously (Orita et al., 1989) . Primer pairs used for this study are shown in Table 1 . Annealing temperature was 62°C for all PCRs. Reactions (10 p.I) were diluted with 50 p~l of 0.1% SDS and 1 mM EDTA and 50 pl of 95% formamide dye. Diluted products were denatured by heating at 94°C for 10 min, and 5 p.I of each sample was separated by electrophoresis on 10% nondenaturing polyacrylamide gels (50:1 acrylamide:bisacrylamide) at 4°C. Electrophoresis was carried out at 50 W for 2-5 hr. Gels were transferred to 3MM filter paper, dried, and exposed to X-ray film at -80°C for 12 hr.
Sequence Analyses of SSCP Conformers
Normal and aberrant SSCP conformers were cut directly from dried gels and eluted in 100 pl of distilled water at 65°C for 30 min. The eluted DNA (10 p.I) was used as template for a second PCR using the original primer pair. Products were fractionated in 2% low melting temperature agarose gels (FMC Corporation), and DNA fragments were purified and sequenced directly by cycle sequencing (Wang and Keating, 1994) . Alternatively, purified PCR products were cloned into pBluescript II SK(+) (Stratagene) using the T-vector method as described previously (Marchuk et al., 1990) . Plasmid DNA samples were purified and sequenced by the dideoxy chain termination method using SequiTherm polymerase (Epicentre Technologies).
